3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Gemcitabine
19
130-nm albumin-bound paclitaxel
16
Specimen Handling
15
Irinotecan
11
Magnetic Resonance Spectroscopy
10
Fluorouracil
10
Leucovorin
9
Biopsy
9
Oxaliplatin
8
pembrolizumab
7
Cyclophosphamide
7
fludarabine
6
Cisplatin
5
Pemetrexed
4
Cetuximab
4
Albumin-Bound Paclitaxel
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
durvalumab
3
dehydroftorafur
3
aldesleukin
3
Taxes
3
Radiosurgery
3
Nivolumab
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
tipifarnib
×
30 days
×
Clear all
No trials found.